Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca M Buffa

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
Cancer|February 27, 2010
hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancerHarriet E Gee, Carme Camps, Francesca M Buffa, et al.
Journal of the National Cancer Institute. Monographs|November 2, 2011
Assessing early therapeutic response to bevacizumab in primary breast cancer using magnetic resonance imaging and gene expression profilesShaveta Mehta, Nicholas P Hughes, Francesca M Buffa, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 20, 2022
WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanomaNicholas Coupe, Lina Guo, Esther Bridges, et al.
Cancer & Metabolism|July 11, 2020
Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cellsMasahiro Kawashima, Karim Bensaad, Christos E Zois, et al.
Molecular Cancer Research : MCR|August 5, 2021
ADGRL4/ELTD1 Expression in Breast Cancer Cells Induces Vascular Normalization and Immune SuppressionHelen Sheldon, Esther Bridges, Ildefonso Silva, et al.
Cancer & Metabolism|August 14, 2020
Correction to: Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cellsMasahiro Kawashima, Karim Bensaad, Christos E Zois, et al.
Cancer Biology & Medicine|September 14, 2019
Identification of anticancer drugs to radiosensitise <i>BRAF</i>-wild-type and mutant colorectal cancerRebecca Carter, Azadeh Cheraghchi-Bashi, Adam Westhorpe, et al.
Molecular Cell|January 4, 2011
miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitorsPatryk Moskwa, Francesca M Buffa, Yunfeng Pan, et al.
British Journal of Cancer|October 4, 2017
IGF-1R associates with adverse outcomes after radical radiotherapy for prostate cancerTamara Aleksic, Clare Verrill, Richard J Bryant, et al.
Molecular Cancer|February 13, 2014
Integrated analysis of microRNA and mRNA expression and association with HIF binding reveals the complexity of microRNA expression regulation under hypoxiaCarme Camps, Harpreet K Saini, David R Mole, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Cancer|February 27, 2010
hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancerHarriet E Gee, Carme Camps, Francesca M Buffa, et al.
Journal of the National Cancer Institute. Monographs|November 2, 2011
Assessing early therapeutic response to bevacizumab in primary breast cancer using magnetic resonance imaging and gene expression profilesShaveta Mehta, Nicholas P Hughes, Francesca M Buffa, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 20, 2022
WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanomaNicholas Coupe, Lina Guo, Esther Bridges, et al.
Cancer & Metabolism|July 11, 2020
Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cellsMasahiro Kawashima, Karim Bensaad, Christos E Zois, et al.
Molecular Cancer Research : MCR|August 5, 2021
ADGRL4/ELTD1 Expression in Breast Cancer Cells Induces Vascular Normalization and Immune SuppressionHelen Sheldon, Esther Bridges, Ildefonso Silva, et al.
Cancer & Metabolism|August 14, 2020
Correction to: Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cellsMasahiro Kawashima, Karim Bensaad, Christos E Zois, et al.
Cancer Biology & Medicine|September 14, 2019
Identification of anticancer drugs to radiosensitise <i>BRAF</i>-wild-type and mutant colorectal cancerRebecca Carter, Azadeh Cheraghchi-Bashi, Adam Westhorpe, et al.
Molecular Cell|January 4, 2011
miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitorsPatryk Moskwa, Francesca M Buffa, Yunfeng Pan, et al.
British Journal of Cancer|October 4, 2017
IGF-1R associates with adverse outcomes after radical radiotherapy for prostate cancerTamara Aleksic, Clare Verrill, Richard J Bryant, et al.
Molecular Cancer|February 13, 2014
Integrated analysis of microRNA and mRNA expression and association with HIF binding reveals the complexity of microRNA expression regulation under hypoxiaCarme Camps, Harpreet K Saini, David R Mole, et al.
Pageof 11